For years, one of the most common questions I heard from people on Medicare was some version of: "My doctor wants me to try one of those new weight-loss drugs, but I heard Medicare doesn't cover them. Is that true?" For a long time, the answer was yes -- Original Medicare and most Part D plans did not cover GLP-1 medications like Wegovy or Zepbound when prescribed for weight loss, even as those drugs transformed how doctors treat obesity.
That changed in 2026. And if you or someone in your family takes these medications or has been waiting to try them, the details matter.
What Changed and When
In late 2025, the White House announced that GLP-1 manufacturers Eli Lilly and Novo Nordisk had agreed to lower their prices for Medicare beneficiaries. CMS confirmed that starting July 1, 2026, Medicare Part D plans will cover these medications for weight management, with out-of-pocket costs capped at $50 per month for qualifying enrollees.
This is genuinely significant. Wegovy, for example, carries a list price of over $1,300 per month without insurance. At $50 a month, the math changes completely for seniors who have been either paying full price out of pocket or going without.
The drugs expected to be covered include Wegovy and Zepbound (the weight-management formulations of semaglutide and tirzepatide), as well as the recently FDA-approved oral Wegovy pill. Ozempic and Mounjaro -- the diabetes-indicated versions of the same drugs -- have been covered under Part D for that use for some time, though coverage specifically for weight loss is new.
Who Qualifies for Coverage
Coverage is not automatic for everyone. To qualify for Part D coverage of GLP-1 medications for weight management, you will generally need to meet these criteria:
- A body mass index (BMI) of 30 or higher, OR a BMI of 27 or higher with at least one weight-related health condition (such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea)
- A prescription from a Medicare-recognized provider who documents medical necessity
- Enrollment in a Part D plan that covers these drugs -- not all plans will automatically include them, so checking your specific plan's formulary matters
The prior authorization requirements will vary by plan. Some Part D plans may require documentation of prior weight-loss attempts or other conditions before approving coverage. Your doctor's office will typically handle the paperwork, but knowing what to expect helps.
Important timing note: Coverage does not begin until July 1, 2026. If you are currently paying out of pocket for a GLP-1 medication, check back with your Part D plan after that date. If you are in the annual out-of-pocket cap window, these costs count toward your $2,000 annual limit.
What About Part D Plans That Don't Cover It
Here is where things get complicated in a way the headlines don't always capture. Medicare Part D plans are required to cover the drugs, but the specific formulary placement -- which tier a drug lands on and what the cost-sharing looks like -- varies by plan. A plan that places a GLP-1 drug in Tier 4 or Tier 5 could still result in costs higher than the $50 cap for some enrollees depending on how the plan structures its tiers.
The safest approach: during the fall Annual Enrollment Period (October 15 to December 7), use Medicare's Plan Finder tool with your specific medication listed. It will show you exactly what each available Part D plan would charge you for your drugs, including GLP-1s if you take them. Do this review every year -- plans change their formularies annually.
Drug Price Negotiation: The Bigger Picture
The GLP-1 coverage is part of a broader shift in how Medicare handles drug pricing. The Inflation Reduction Act gave CMS the authority to negotiate prices directly with drug manufacturers for the first time in Medicare's history. In 2026, ten drugs have new negotiated Maximum Fair Prices in effect, with the savings expected to reduce beneficiary out-of-pocket spending by an estimated $1.5 billion this year alone.
Fifteen more drugs are scheduled to have negotiated prices take effect in January 2027. If you take any expensive brand-name medications, it is worth checking whether your drugs are on the negotiation list -- the savings can be substantial. The current list of negotiated drugs is published at medicare.gov.
If You're Currently Paying Full Price
A few practical notes for people currently taking GLP-1 medications:
If you are paying out of pocket or through a private insurer, keep your receipts and documentation. When Medicare coverage begins in July, your prescribing physician will need to verify your diagnosis and document medical necessity -- having your history in order speeds that process up considerably.
If your income is limited, look into Medicare's Extra Help program. People who qualify for Extra Help already pay very low or no costs for Part D drugs, and GLP-1 coverage under Extra Help will follow the same reduced cost-sharing structure.
If your doctor has been recommending a GLP-1 drug and cost has been the barrier, July 2026 is worth putting on your calendar.
Bottom Line
Medicare Part D will cover GLP-1 weight-loss medications starting July 1, 2026, at a cap of $50 per month for qualifying beneficiaries. Check your specific Part D plan's formulary during fall open enrollment to confirm coverage and costs for your situation. If your income is limited, Extra Help may lower costs even further.
Sources & References
Ben built this site after spending months trying to find straight answers about Medicare for his own father. He writes to give people the clear, unbiased information he wished he had found the first time. Read his full story.
Disclaimer: The information on this site is for educational purposes only and does not constitute legal, financial, or medical advice. Medicare rules and costs change annually. Always verify current information at Medicare.gov or by calling 1-800-MEDICARE. Consider consulting a licensed insurance professional or your State Health Insurance Assistance Program (SHIP) for personalized guidance.